Equities researchers at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The company has a market capitalization of $833,000.00, a P/E ratio of 0.00 and a beta of -0.90.
About Athersys
Further Reading
- Five stocks we like better than Athersys
- What is a support level?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is the FTSE 100 index?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Learn Technical Analysis Skills to Master the Stock Market
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
